Skip to main content
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2023 Aug 2;44(12):2549. doi: 10.1038/s41401-023-01130-6

Author Correction: Pharmacokinetics, mass balance, and metabolism of [14C]vicagrel, a novel irreversible P2Y12 inhibitor in humans

Yuan-dong Zheng 1,2,#, Hua Zhang 3,4,#, Yan Zhan 1,2, Yi-cong Bian 3,4, Sheng Ma 3,4, Hai-xian Gan 1, Xiao-juan Lai 5, Yong-qiang Liu 5, Yan-chun Gong 5, Xue-fang Liu 5, Hong-bin Sun 6, Yong-guo Li 7, Da-fang Zhong 1,2,, Li-yan Miao 3,4,, Xing-xing Diao 1,2,
PMCID: PMC10692069  PMID: 37532785

Correction to: Acta Pharmacologica Sinica 10.1038/s41401-020-00547-7, published online 26 November 2020

The authors apologized for the mistake in Fig. 3b, the mean concentration of metabolites M3, M9-2, M15-1, and M15-2 in plasma were provided incorrectly. These errors were made completely by accident.

The conclusion of the original article or the context of the article was not affected. The corrected figure is presented as follow. The authors deeply apologized for any inconvenience caused to the Journal and readers.

Fig. 3. Radioactive pharmacokinetics, LC-MS/MS analysis, mass balance.

Fig. 3

b Mean concentration of metabolites M3, M9-2, M15-1, and M15-2 in plasma.

Contributor Information

Da-fang Zhong, Email: dfzhong@simm.ac.cn.

Li-yan Miao, Email: miaolysuzhou@163.com.

Xing-xing Diao, Email: xxdiao@simm.ac.cn.


Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES